GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Merus NV (STU:2GH) » Definitions » Shiller PE Ratio

Merus NV (STU:2GH) Shiller PE Ratio : (As of Jun. 10, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Merus NV Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Merus NV Shiller PE Ratio Historical Data

The historical data trend for Merus NV's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus NV Shiller PE Ratio Chart

Merus NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Merus NV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Merus NV's Shiller PE Ratio

For the Biotechnology subindustry, Merus NV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merus NV's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Merus NV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merus NV's Shiller PE Ratio falls into.



Merus NV Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Merus NV's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Merus NV's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.543/128.5800*128.5800
=-0.543

Current CPI (Mar. 2024) = 128.5800.

Merus NV Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.000 99.240 0.000
201409 -0.260 99.960 -0.334
201412 -0.336 99.050 -0.436
201503 -0.314 99.750 -0.405
201506 -0.361 100.230 -0.463
201509 -0.399 100.500 -0.510
201512 -0.402 99.730 -0.518
201603 -0.390 100.310 -0.500
201606 -0.396 100.260 -0.508
201609 -0.310 100.570 -0.396
201612 -1.904 100.710 -2.431
201703 -1.059 101.440 -1.342
201706 -1.028 101.370 -1.304
201709 -0.680 102.030 -0.857
201712 -0.740 101.970 -0.933
201803 -0.400 102.470 -0.502
201806 -0.198 103.100 -0.247
201809 -0.468 103.950 -0.579
201812 -0.020 103.970 -0.025
201903 -0.336 105.370 -0.410
201906 -0.460 105.840 -0.559
201909 -0.499 106.700 -0.601
201912 -0.738 106.800 -0.889
202003 -0.615 106.850 -0.740
202006 -0.480 107.510 -0.574
202009 -0.543 107.880 -0.647
202012 -0.871 107.850 -1.038
202103 -0.235 108.870 -0.278
202106 -0.589 109.670 -0.691
202109 -0.332 110.790 -0.385
202112 -0.301 114.010 -0.339
202203 -0.390 119.460 -0.420
202206 -0.123 119.050 -0.133
202209 -0.535 126.890 -0.542
202212 -1.709 124.940 -1.759
202303 -0.803 124.720 -0.828
202306 -0.609 125.830 -0.622
202309 -0.403 127.160 -0.408
202312 -1.000 126.450 -1.017
202403 -0.543 128.580 -0.543

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Merus NV  (STU:2GH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Merus NV Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Merus NV's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Merus NV (STU:2GH) Business Description

Traded in Other Exchanges
Address
Uppsalalaan 17, Utrecht, NLD, 3584 CT
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Merus NV (STU:2GH) Headlines

No Headlines